The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder
Clinical trial NCT03324581 · COMPLETED
Trial details
- NCT number
- NCT03324581
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-09
- Primary completion
- 2018-10-31
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.